News Chart Dianthus Therapeutics, Inc.

Equities

DNTH

US2528281080

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 02:00:55 2024-09-18 pm EDT			5-day change	1st Jan Change
26.58 ^USD	+2.29%		-6.51%	+149.90%

Aug. 09	Wedbush Adjusts Dianthus Therapeutics' PT to $36 From $38, Keeps Outperform Rating	MT
Aug. 08	Dianthus Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI

67c623ec75b5a19e4a4a6015fb.uQuYynhFJBGFSxW4nrvtCyollmffZXcPnKvkBWg10c4.7CbeoQsaY07RekLz58qdbhJc_C2LXDhHxoaXbQldo5_sTe6lDxddXNwDeg~cc62e5840483410916e4dd188542f6ad